A dedicated certification pathway for programmes delivering Immune Effector Cell therapies
JACIE offers a dedicated certification pathway for programmes delivering Immune Effector Cell (IEC) therapies outside traditional Haematopoietic Cell Transplantation (HCT) settings.
Based on the FACT-JACIE International Standards for Immune Effector Cells, Third Edition (Version 3.1), this pathway provides an internationally recognised framework for quality management, clinical practice and patient safety.
Importantly, centres do not need to perform haematopoietic stem cell transplantation to apply for JACIE IEC certification.
Who can apply?
The IEC certification pathway is designed for programmes administering, collecting and/or processing Immune Effector Cell (IEC) therapies outside a transplant setting, including:
- Oncology and haemato-oncology departments.
- Autoimmune disease programmes.
- Dedicated cellular therapy units.
- Clinical trial facilities.
- Standalone IEC treatment centres.
- Other healthcare programmes administering eligible IEC therapies.
The IEC pathway is independent of HCT certification and is specifically designed for programmes whose activities focus exclusively on IEC therapies.
Which therapies are covered?
Immune Effector Cells include cells capable of modulating or effecting a specific immune response.
Examples include:
- Chimeric Antigen Receptor T-cell (CAR-T) therapies.
- CAR-NK cell therapies.
- Tumour-Infiltrating Lymphocyte (TIL) therapies.
- Dendritic cell vaccines.
- Other eligible immune effector cell products covered by the FACT-JACIE Standards.
Please consult the applicable FACT-JACIE IEC Standards for the formal definition and scope. Donor lymphocyte infusions (DLI) are not considered IECs for the purposes of these Standards.
Are there minimum activity requirements?
Yes. The FACT-JACIE IEC Standards establish minimum clinical activity requirements for programmes applying for IEC certification.
Under the Third Edition of the IEC Standards, programmes applying through the IEC pathway must have treated at least five new patients with immune effector cell therapies prior to initial certification and must meet this minimum activity requirement annually thereafter, per clinical site.
Centres should consult Appendix I of the Standards and the Accreditation Manual for the full requirements and applicable definitions.
How much does the certification cost?
Please visit the Certification fees website.
How to apply
Centres interested in obtaining JACIE IEC certification are encouraged to follow these initial steps:
Step 1 – Contact JACIE
Contact the JACIE Office at jacie@ebmt.org to express your interest and discuss your programme's activities and eligibility. Read the JACIE 171 IEC Applicant's guide below.
Step 2 – Review the applicable Standards
Review the FACT-JACIE International Standards for Immune Effector Cells, Third Edition (Version 3.1), together with the accompanying Accreditation Manual.
Step 3 – Assess your programme
Review your existing clinical activities, organisational structure, quality management system, personnel, facilities and procedures against the applicable Standards.
Step 4 – Prepare and submit your application
Submit the completed JACIE 172 IEC Application form and JACIE 173 IEC Self-assessment Checklist, which can be found below.
Documentation to prepare for Certification
Centres interested in applying are strongly encouraged to read the JACIE IEC Applicant's Guide before submitting an application. The guide provides detailed information on eligibility, certification requirements, the application process and inspection arrangements.